Resp Care
-
Aerosolized albuterol is commonly used in the treatment of neonatal respiratory illnesses. Clinical and in vitro studies have identified numerous factors that affect aerosol drug delivery during neonatal mechanical ventilation, including the choice of metered-dose inhaler (MDI) or nebulizer, the use of a holding chamber, time between actuations, the volume of nebulized solution, and the position and placement of the nebulizer or MDI. Because there is no consensus on the optimal method of administration, there is probably substantial variability among institutions in how aerosolized albuterol is administered to mechanically ventilated infants in the neonatal intensive care unit (NICU). ⋯ There is substantial variability among NICUs in albuterol administration to mechanically ventilated infants, with the majority of institutions now administering albuterol via MDI.
-
Motion artifact and low perfusion often lead to faulty or absent pulse oximetry readings in clinical practice. ⋯ The established model of creating motion artifact and low perfusion is capable of simulating a hierarchy of severe clinical situations. With solely motion or solely reduced perfusion the percentage of errors exceeding +/- 3% of S(pO(2)) increased by 20% and 10%, respectively, compared to the control period. Simultaneous presence of motion and reduced perfusion leads to a relative incidence of > 35% of errors > 3% of S(pO(2)) for the various oximeters. In this situation the N-3000 and the Datex-Ohmeda 3900P exhibited differences between estimated pulse rate and electrocardiographically-measured heart rate > 25 beats/min > 37% of the time.
-
Partial liquid ventilation improves lung mechanics and gas exchange in paralyzed mechanically ventilated animals. ⋯ In this pilot study of healthy animals breathing spontaneously with perflubron-filled lungs, there was an acceptable amount of WOB, which decreased with the addition of PSV. However, WOB increased when the perflubron level was not maintained at functional residual capacity.